Investigative Site

New York, New York 10065

1 studies enrolling now · 11 studies all time

What they study most

Beta-Thalassemia, Constipation, Heavy Menstrual Bleeding, Hereditary Hemochromatosis, Hidradenitis Suppurativa, Menorrhagia, Obesity, Opioid-induced Constipation, Overweight, Postherpetic Neuralgia, Psoriasis, Tumor Hyperinsulinism (Tumor HI)

Studies at this site

• A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism — Recruiting now
• A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection — Running, not enrolling
• A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa — Completed
• Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes — Completed
• A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis — Completed
• A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis — Completed
• A Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Patients With Transfusion-Dependent Beta Thalassemia — Stopped early
• Efficacy and Safety of XP12B in Women With Menorrhagia — Completed
• Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia — Completed
• Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain. — Stopped early
• Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain — Stopped early